Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Daily Stock Opinions and Ratings
Stockchase Opinions

Andrew McCreathInex Pharmaceuticals CorpIEX.TOBUYMay 29, 2003

If you like biotechs, this could be OK. Speculative.
Andrew McCreathAndrew McCreath
Unknown
Unlock Rating
$4.55

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

COMMENT

Inex Pharmaceuticals Corp(IEX.TO)

Apr 17, 2007
This is a penny stock and they tend to be promoted.
Photo of Kenneth P. Norquay, CMTKenneth P. Norquay, CMT
No
Unlock Rating
$1.10

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Inex Pharmaceuticals Corp(IEX.TO)

Mar 24, 2004
A well-run company. Probably one of the lower risk biotech investments in Canada. Their product Onco TCS should be approved this year. Have a good marketing partnership with Enzon.
Photo of Ed HoEd HoUnlock Rating
$7.43

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Inex Pharmaceuticals Corp(IEX.TO)

Apr 04, 2003
Need to get FDA approval. Too speculative for their funds.
Photo of David BaskinDavid BaskinUnlock Rating
$3.69

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Inex Pharmaceuticals Corp(IEX.TO)

Feb 10, 2003
Good cash balance. Their problemsare delays in getting their product to market. Needs a good partner.
Photo of Mike WeirMike WeirUnlock Rating
$3.77

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Inex Pharmaceuticals Corp(IEX.TO)

Jan 16, 2003
Needs approval by FDA. Nice cash balance.
Photo of Mike WeirMike WeirUnlock Rating
$4.14

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Inex Pharmaceuticals Corp(IEX.TO)

Dec 06, 2002
There will be some delay in their filings with FDA.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$4.90

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Inex Pharmaceuticals Corp(IEX.TO)

Mar 21, 2002
In phase 3 trials. Speculative.
Photo of Bruce CooperBruce CooperUnlock Rating
$6.50

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Inex Pharmaceuticals Corp(IEX.TO)

Mar 06, 2002
(Was a top pick on Dec 5 no change) Still likes.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$7.15

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Inex Pharmaceuticals Corp(IEX.TO)

Dec 05, 2001
A speculative choice, but has a good RISK/RETURN.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$7.55

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Inex Pharmaceuticals Corp(IEX.TO)

May 04, 2001
Just partnered which is good. Good company
Photo of Malvin SpoonerMalvin SpoonerUnlock Rating
$6.70

Stock price when the opinion was issued

biotechnologypharmaceutical
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica